Page last updated: 2024-10-16

5-hydroxytryptophan and Brain Neoplasms

5-hydroxytryptophan has been researched along with Brain Neoplasms in 1 studies

5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trimble, M1
Chadwick, D1
Reynolds, EH1
Marsden, CD1

Other Studies

1 other study available for 5-hydroxytryptophan and Brain Neoplasms

ArticleYear
Letter: L 5-Hydroxytryptophan and mood.
    Lancet (London, England), 1975, Mar-08, Volume: 1, Issue:7906

    Topics: 5-Hydroxytryptophan; Affective Symptoms; Aggression; Brain Neoplasms; Depression; Dose-Response Rela

1975